10 years of historical data (2015–2024) · Technology · Consumer Electronics
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Zepp Health Corporation currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $2.3B | $11M | $22M | $22M | $83M | $193M | $194M | $138M | — | — | — |
| Enterprise Value | $2.3B | $532M | $413M | $765M | $-76859056 | $-1350496957 | $-1480411056 | $-1276558180 | — | — | — |
| P/E Ratio → | -0.97 | — | — | — | 3.85 | 5.49 | 0.34 | 1.21 | — | — | — |
| P/S Ratio | 11.63 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | 0.03 | 0.04 | — | — | — |
| P/B Ratio | 0.29 | 0.01 | 0.01 | 0.01 | 0.03 | 0.07 | 0.08 | 0.08 | — | — | — |
| P/FCF | — | — | 0.53 | — | — | 2.69 | 0.47 | 0.20 | — | — | — |
| P/OCF | — | — | 0.51 | — | — | 1.28 | 0.44 | 0.19 | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.40 | 0.17 | 0.18 | -0.01 | -0.22 | -0.26 | -0.34 | — | — | — |
| EV / EBITDA | — | — | — | — | -0.53 | -7.10 | -2.33 | -3.30 | — | — | — |
| EV / EBIT | — | — | — | — | -0.51 | -5.38 | -2.28 | -3.18 | — | — | — |
| EV / FCF | — | — | 10.10 | — | — | -18.81 | -3.62 | -1.82 | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Zepp Health Corporation earns an operating margin of -25.9%. Operating margins have compressed from -9.9% to -25.9% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -25.5% indicates the company is currently destroying shareholder equity.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 38.5% | 38.5% | 26.2% | 19.4% | 20.9% | 20.7% | 25.3% | 25.8% | 24.1% | 17.7% | 12.3% |
| Operating Margin | -25.9% | -25.9% | -8.6% | -9.9% | 1.5% | 2.7% | 10.7% | 10.0% | 8.9% | 0.9% | -4.5% |
| Net Profit Margin | -41.6% | -41.6% | -8.8% | -7.0% | 2.2% | 3.6% | 9.9% | 9.3% | 8.2% | 1.5% | -4.2% |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -25.5% | -25.5% | -8.6% | -10.5% | 4.8% | 8.3% | 26.8% | 29.5% | 35.4% | 8.5% | -15.6% |
| ROA | -13.3% | -13.3% | -4.5% | -5.2% | 2.3% | 3.9% | 13.7% | 14.9% | 13.3% | 3.3% | -7.4% |
| ROIC | -9.8% | -9.8% | -5.1% | -10.2% | 3.5% | 12.5% | 77.8% | 88.4% | 60.0% | 9.3% | -105.7% |
| ROCE | -11.8% | -11.8% | -6.2% | -11.2% | 2.6% | 5.7% | 27.3% | 30.8% | 38.0% | 4.7% | -16.5% |
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $521M ($1.3B total debt minus $808M cash).
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.72 | 0.72 | 0.55 | 0.64 | 0.46 | 0.27 | 0.04 | 0.02 | 0.07 | 0.04 | — |
| Debt / EBITDA | — | — | — | — | 9.36 | 3.82 | 0.17 | 0.10 | 0.21 | 0.77 | — |
| Net Debt / Equity | — | 0.28 | 0.16 | 0.28 | -0.05 | -0.57 | -0.68 | -0.78 | -0.58 | -0.42 | -0.88 |
| Net Debt / EBITDA | — | — | — | — | -1.11 | -8.11 | -2.63 | -3.66 | -1.86 | -8.65 | — |
| Debt / FCF | — | — | 9.57 | — | — | -21.50 | -4.09 | -2.01 | -1.61 | -31.53 | — |
| Interest Coverage | -8.51 | -8.51 | -4.51 | -7.20 | 2.09 | — | — | — | — | — | — |
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.29x means Zepp Health Corporation can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has declined from 1.77x to 1.29x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.29 | 1.29 | 2.04 | 1.77 | 1.83 | 1.73 | 1.77 | 2.06 | 1.46 | 1.36 | 1.87 |
| Quick Ratio | 1.00 | 1.00 | 1.49 | 1.16 | 1.24 | 1.29 | 1.41 | 1.70 | 1.17 | 1.05 | 1.54 |
| Cash Ratio | 0.57 | 0.57 | 0.94 | 0.60 | 0.71 | 0.82 | 0.73 | 1.15 | 0.44 | 0.26 | 0.80 |
| Asset Turnover | — | 0.35 | 0.55 | 0.81 | 1.01 | 1.03 | 1.13 | 1.16 | 1.35 | 1.67 | 1.75 |
| Inventory Turnover | 1.98 | 1.98 | 3.07 | 3.37 | 3.89 | 3.97 | 4.89 | 5.70 | 5.88 | 6.92 | 8.97 |
| Days Sales Outstanding | — | 158.12 | 84.86 | 74.27 | 64.29 | 76.65 | 103.66 | 73.10 | 118.51 | 111.83 | 81.05 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Zepp Health Corporation returns 0.0% to shareholders annually primarily through share buybacks.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | 28.2% | — | — | 2.3% | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | 0.8% | — | — | — | — |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | 25.9% | 18.2% | 298.2% | 82.6% | — | — | — |
| FCF Yield | — | — | 189.6% | — | — | 37.2% | 210.9% | 508.6% | — | — | — |
| Buyback Yield | 0.0% | 21.7% | 11.7% | 36.6% | 16.3% | 0.0% | 0.0% | 6.1% | — | — | — |
| Total Shareholder Yield | 0.0% | 21.7% | 11.7% | 64.8% | 16.3% | 0.0% | 2.3% | 6.1% | — | — | — |
| Shares Outstanding | — | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M |
Compare ZEPP with 2 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| ZEPPYou | $2B | -1.0 | — | — | 38.5% | -25.9% | -25.5% | -9.8% | — |
| VUZI | $229M | -2.7 | — | — | -84.5% | -1285.4% | -124.5% | -149.7% | — |
| WLDS | $539016 | -0.0 | — | — | 16.3% | -1498.1% | -167.9% | -164.2% | — |
| Technology Median | — | 25.2 | 15.7 | 17.3 | 49.8% | -0.9% | 1.1% | 2.9% | 3.0 |
Peers based on L4 peer group classification. Compare multiple stocks →
Includes 30+ ratios · 10 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how ZEPP stacks up against sector leader Vuzix Corporation.
Start ComparisonZepp Health Corporation's current P/E ratio is -1.0x. The historical average is 2.7x.
Zepp Health Corporation's return on equity (ROE) is -25.5%. The historical average is 5.3%.
Based on historical data, Zepp Health Corporation is trading at a P/E of -1.0x. Compare with industry peers and growth rates for a complete picture.
Zepp Health Corporation has 38.5% gross margin and -25.9% operating margin.